| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/12/2002 | WO2001047562A3 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 09/12/2002 | WO2001047497A3 Controlled release pharmaceutical composition containing tramadol hydrochloride |
| 09/12/2002 | WO2001041794A3 Activated amylase |
| 09/12/2002 | WO2001041753A3 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 09/12/2002 | WO2001036510A3 Use of poly(diallylamine) polymers |
| 09/12/2002 | WO2001034174A3 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 09/12/2002 | WO2001015694A9 Extended duration light activated cancer therapy |
| 09/12/2002 | WO2001012247A9 Tissue augmentation material and method |
| 09/12/2002 | US20020128527 Use in medicine, pharmacy, biology and technology, friction-reducing additives in engines |
| 09/12/2002 | US20020128434 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/12/2002 | US20020128345 High molecular weight rubber and less than about 60 parts by weight of a liquid diluent, and having a G' of less than about 15 x 104 dynes/cm2 at 10 rad/s at 25 degrees C. |
| 09/12/2002 | US20020128326 Topical immunomodulating compositions for treatment of aids, hepatitis b&c, other infectious diseases, and cancer |
| 09/12/2002 | US20020128325 Process for producing dry powders of one or more carotenoids |
| 09/12/2002 | US20020128322 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 09/12/2002 | US20020128313 Administering to the herd native or extended semen with a simultaneous or sequential administration of prostaglandin |
| 09/12/2002 | US20020128310 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammtory formulation |
| 09/12/2002 | US20020128291 Following surgery or trauma or resulting in ocular diseases associated with choroidal neovascularization, such as age related macular degeneration and histoplasmosis syndrome |
| 09/12/2002 | US20020128239 > 1 x 10-7 mole per liter of a vitamin D compound in an acceptable lipid; anticancer agents |
| 09/12/2002 | US20020128229 Treating symptoms of menopause; improves water solubility of drospirenone |
| 09/12/2002 | US20020128225 Methods and products related to pulmonary delivery of polysaccharides |
| 09/12/2002 | US20020128222 Methods to enhance wound healing and enhanced wound coverage material |
| 09/12/2002 | US20020128218 Therapeutic delivery compositions and methods of use thereof |
| 09/12/2002 | US20020128207 Dried blood factor composition comprising trehalose |
| 09/12/2002 | US20020128204 Pharmaceutical formulation for intravenous or intramuscular octreotide administration |
| 09/12/2002 | US20020128202 Stimulation of bone growth with thrombin peptide derivatives |
| 09/12/2002 | US20020128195 Hydrophilic polymer covalently and reversibly linked to amine-containing ligand through dithiobenzyl linkage; improves blood circulation time |
| 09/12/2002 | US20020128177 For protecting a chemical compound from degradation |
| 09/12/2002 | US20020127675 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 09/12/2002 | US20020127652 Polypeptide for use in the treatment of mammalian sexual disorders |
| 09/12/2002 | US20020127321 Process for producing a powder containing crystalline particles of maltitol |
| 09/12/2002 | US20020127303 Used for multivitamin tablets, hard gelatin capsules, dry food and feed compositions and for enriching sugar |
| 09/12/2002 | US20020127281 Stabilized hyrogen peroxide solutions |
| 09/12/2002 | US20020127272 For use as delivery vehicles for biologically active molecules |
| 09/12/2002 | US20020127251 For use in make-up such as foundations, powders, mascaras, eyeliners, lipsticks or products for making up the hair, deodorant products, in particular in the form of sticks or cream, protection creams, wipes |
| 09/12/2002 | US20020127249 Novel formulation for use in pain management |
| 09/12/2002 | US20020127244 Fractionating a mixture of polyethylene glycol(PEG)-protein adducts comprising partitioning the PEG/protein adducts in a PEG-containing aqueous biphasic system |
| 09/12/2002 | US20020127232 Activating alpha 2-macroglobulin by incubation with a nucleophilic compound to form nucleophile-activated alpha 2-macroglobulin, removing excess of nucleophilic compound, incubating activated alpha-2 macroglobulin with biomolecule |
| 09/12/2002 | US20020127229 Tumour therapy |
| 09/12/2002 | US20020127223 Binding antibodies or antiboy-comparable with affinity for body cells not meant to be affected by chemotherapeutical drug directly to an antidote or to carriers such as proteins, or microbody carriers such as liposomes, erythroctes |
| 09/12/2002 | US20020127215 Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 09/12/2002 | US20020127209 Tripeptide of intracellular tyrosine-based activation motifs (ITAM) mediates trafficking of targets phagocytosed via Fc gamma RIIA to the lysosomal compartment |
| 09/12/2002 | US20020127202 Compounds and compositions for delivering active agents |
| 09/12/2002 | US20020127198 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | US20020127190 Mucoadhesive film, of a homogeneous mixture of a water-soluble polymer, a polyalcohol, a cosmetically and/or pharmaceutically active agent, and a flavor |
| 09/12/2002 | US20020127185 Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide |
| 09/12/2002 | US20020127181 Antagonist diamidediphenolate compounds attached to a metal chelate and linking group; use as contrast agents for X-ray imaging and magnetic resonance imaging |
| 09/12/2002 | DE10111058A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten New pharmaceutical compositions based on anticholinergics and NK¶1¶ receptor antagonists |
| 09/12/2002 | DE10111045A1 Cosmetic or dermatological preparations, useful e.g. for treating inflammatory skin disorders, pigmentation disorders or aging, containing combination of alpha-lipoic acid and (iso)flavone, flavanone or flavonoid |
| 09/12/2002 | DE10110855A1 Use of glycerine carbonate and its derivatives e.g. as solvent for production of dyes and paints, in cosmetic compositions, in washing and cleansing agents and in adhesives |
| 09/12/2002 | DE10110772A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren New pharmaceutical compositions based on anticholinergics and PDE IV inhibitors |
| 09/12/2002 | DE10110336A1 Tensidfreie kosmetische, dermatologische und pharmazeutische Mittel Surfactant-free cosmetic, dermatological and pharmaceutical agents |
| 09/12/2002 | DE10108851A1 Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten Use of 5'-substituted nucleosides and / or their prodrugs for the resistance-free therapy of infectious diseases |
| 09/12/2002 | DE10107261A1 Pharmazeutische Zusammensetzung Pharmaceutical composition |
| 09/12/2002 | CA2659188A1 Porous beta-tricalcium phosphate granules and methods for producing same |
| 09/12/2002 | CA2440235A1 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| 09/12/2002 | CA2440141A1 Compounds and methods for the treatment of urogenital disorders |
| 09/12/2002 | CA2440128A1 Hydrogel attached to backing and method for making same |
| 09/12/2002 | CA2440070A1 Pharmaceutical composition made of cannabis extracts |
| 09/12/2002 | CA2440069A1 Taste masked pharmaceutical compositions |
| 09/12/2002 | CA2439917A1 Compositions having improved bioavailability of eletriptan |
| 09/12/2002 | CA2439915A1 New pharmaceutical compositions based on anticholinergics and nk1-receptor antagonists |
| 09/12/2002 | CA2439873A1 Intraorally rapidly desintegrable tablet |
| 09/12/2002 | CA2439574A1 Catecholate beta-lactam conjugates, method for producing the same and the use thereof |
| 09/12/2002 | CA2438849A1 Compounds and compositions for delivering active agents |
| 09/12/2002 | CA2438847A1 Amphotericin b aqueous composition |
| 09/12/2002 | CA2438326A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | CA2435277A1 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/11/2002 | EP1239043A2 Fusion proteins comprising tumour necrosis factor receptor |
| 09/11/2002 | EP1238678A1 Enzyme-activated cytostatic conjugates with integrin ligands |
| 09/11/2002 | EP1238677A2 Parenteral fat emulsions comprising edetate as preservative |
| 09/11/2002 | EP1238675A1 Recombinant gelatin-like proteins for use as plasma expanders |
| 09/11/2002 | EP1238664A1 Adhesive preparations |
| 09/11/2002 | EP1238644A1 Stabilizers for l-ascorbic acid-2-sodium phosphate |
| 09/11/2002 | EP1238282A2 Methods of diagnosis and treatment by binding p75/airm1 |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238016A1 Substituted phthalocyanines and their precursors |
| 09/11/2002 | EP1237996A1 Water unstable foam |
| 09/11/2002 | EP1237988A1 Method for producing nanoparticulate chitosans or chitosan derivatives |
| 09/11/2002 | EP1237915A2 Polynucleotid encoding the rg1 polypeptide |
| 09/11/2002 | EP1237872A1 Compounds and compositions for delivering active agents |
| 09/11/2002 | EP1237585A1 Mineral-polymer hybrid composition |
| 09/11/2002 | EP1237581A1 Use of cationic lipids for intracellular protein delivery |
| 09/11/2002 | EP1237580A2 Amphiphilic polymers and polypeptide conjugates comprising same |
| 09/11/2002 | EP1237578A2 Micro-cluster liquids and methods of making and using them |
| 09/11/2002 | EP1237561A2 Use of honey in medical dressings |
| 09/11/2002 | EP1237558A1 Novel helicobacter pylori-binding substances and use thereof |
| 09/11/2002 | EP1237556A2 Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| 09/11/2002 | EP1237555A2 Implant composition containing melengestrol acetate and trenbolone acetate |
| 09/11/2002 | EP1237551A1 Pharmaceutical formulations containing zolmitriptan |
| 09/11/2002 | EP1237544A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 09/11/2002 | EP1237543A1 Effervescent histamine h2 antagonist composition |
| 09/11/2002 | EP1237542A1 Foam coatings and foam coated compositions |
| 09/11/2002 | EP1237540A2 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| 09/11/2002 | EP1237539A1 Oral solution containing galanthamine and a sweetening agent |
| 09/11/2002 | EP1237537A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 09/11/2002 | EP1237536A1 The use of fluorescent whitening agents |
| 09/11/2002 | EP1237424A1 Composition for improving the proliferative response during adaptation of the gastrointestinal tract and use in short bowel syndrome |
| 09/11/2002 | EP1237423A1 Stable, spray-dried composition in a carbohydrate substrate and process for obtaining said composition |
| 09/11/2002 | EP1237408A2 Pour-on formulations |
| 09/11/2002 | EP1207908A4 Method of treating body insect infestation |